Actor Kagiso Modupe Set To Be Circumcised

Advertisement

After much investigation, Scandal! actor Kagiso Modupe, has decided to get medically circumcised as part of a health initiative.

In addition, the actor is calling on 2000 men across the country to join him in the campaign to avoid the consequences of not getting circumcised.

Read: Kisses For Sale: Manaka Ranaka Launches Unusual Initiative For The Greater Good

As part of the Department of Health’s circumcision programme, the Brother for Life ambassador is encouraging men to book a medical circumcision by sending a ‘please call me’ to 082 808 6152 to secure a slot at #ZwakalaSkeem (come with me brother) day at one of 150 clinics in Gauteng, KZN, Mpumalanga and the North West.

Kagiso was quoted in a press release saying;



“I would like South African men to join me in a celebration of masculinity, brotherhood and good health. I’m calling on men to be circumcised with me on Saturday, 11 March 2017.”

“I was motivated to have this done when I read how it can protect my wife from getting human papillomavirus (HPV) which causes cervical cancer. But I’ve learnt that in a recent survey of 100 000 men, 47% do it for hygiene reasons and 38% for HIV prevention. Circumcision reduces the risk of contracting HIV by 60% as well as other sexually transmitted infections. Some men do it because it keeps the penis clean, and others because their partners prefer it, but whatever the reason, it’s the right thing to do,” the star added.

Actor Kagiso

Read Also: Record Label Ambitiouz Releases Official Statement On The Mass Exodus Plaguing The Stable

Subsequently, Scandal! actor Kagiso will undergo the procedure at the Katlehong North Clinic. To spice up the whole initiative, the actor invited the Mini car club, a local DJ and the Ridge Riders Motorcycle Club to be there to celebrate the men who will step forward to get circumcised. His wife, Liza Modupe will also be present during the celebrations. She has been very supportive of his decision to get rid of his foreskin.

Topics: